MustGrow Biologics Corp. (MGRO : TSX-V)
Common Stock
Follow MGRO
MGRO
MustGrow Biologics Corp.
Performance
1 Day
+1.23%
1 Week
+2.50%
1 Month
-3.53%
YTD
-34.92%
The Saturday TSX Wrap · free, every saturday morning. The week on the TSX, in five minutes.
Key Statistics
Market Cap
$28.86M
52W High
$0.94
52W Low
$0.29
P/E Ratio
-
50 Day MA
$0.41
200 Day MA
$0.49
Beta
0.39
Dividend Yield
-
Performance history
MGRO returns since 2023
MustGrow Biologics Corp. has traded since Nov 2023 in our data, with 0 up years out of 2 full calendar years. Its deepest fall was −86.8% (Oct 2024 to Jul 2026).
1 year / yr
−40.2%
3 years / yr
−30.6%
5 years / yr
—
10 years / yr
—
Calendar-year returns
- 2023*+7.5%
- 2024−10.9%
- 2025−45.2%
- 2026*−37.3%
* Partial year (first year of data, or year to date).
$10,000 invested in MGRO
- 1 year ago$5,985
- 2023 (start of our data)$3,292
- Best year
- 2024: −10.9%
- Worst year
- 2025: −45.2%
- All-time high in our data
- $2 on Oct 28, 2024 · now −82.9%
Total-return basis using adjusted daily closes from the Toronto Stock Exchange and TSX Venture (dividends and splits folded in), Nov 2023 to Nov 2026. Past returns do not predict future ones.
Awesome Portfolio™
Looking past MGRO? Our 10 best Canadian stocks, in one list.
14.8% a year since 2017 against 9.7% for the S&P/TSX Composite (+5.0 points a year). Reviewed every month.
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 11/10/2026 | $0.40 | $0.40 | $0.40 | $0.40 | $0.40 | 2,000 |
| 11/9/2026 | $0.41 | $0.43 | $0.38 | $0.41 | $0.41 | 45,500 |
| 11/6/2026 | $0.40 | $0.41 | $0.38 | $0.41 | $0.41 | 17,500 |
| 11/5/2026 | $0.41 | $0.41 | $0.39 | $0.39 | $0.39 | 13,525 |
| 11/4/2026 | $0.40 | $0.40 | $0.36 | $0.39 | $0.39 | 53,557 |
| 11/3/2026 | $0.40 | $0.42 | $0.37 | $0.41 | $0.41 | 69,200 |
| 11/2/2026 | $0.38 | $0.42 | $0.36 | $0.40 | $0.40 | 96,500 |
| 10/30/2026 | $0.37 | $0.38 | $0.36 | $0.36 | $0.36 | 25,741 |
| 10/29/2026 | $0.41 | $0.41 | $0.38 | $0.38 | $0.38 | 8,685 |
| 10/28/2026 | $0.42 | $0.43 | $0.38 | $0.38 | $0.38 | 29,035 |
Analyst Price Targets
Based on analyst covering MGRO · as of Sep 30, 2026
Wall Street analysts forecast MGRO stock price to rise 512.2% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$2.51
+512.2% Upside
Previously C$2.70 on Sep 17, 2026
Current Price
C$0.41
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MGRO's historical volatility
30-Day Vol
92.8%
Annualized
90-Day Vol
88.8%
Annualized
Trend (90d)
-30.7%
Annualized drift
90d Mean
C$0.35
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.38 | C$0.28 – C$0.52 |
| 60 trading days | C$0.37 | C$0.23 – C$0.58 |
| 90 trading days | C$0.35 | C$0.20 – C$0.62 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About MustGrow Biologics Corp.
MustGrow Biologics Corp., an agricultural biotechnology company, focuses on development and commercialization of natural biological technologies and products from mustard plants. The company provides Biocontrol technology platform to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and others; treat unwanted plant growth for use in organic agriculture, and home and garden markets, as well as agriculture markets where glyphosate has been banned; and suppress sprouting, and treat disease and pathogen for storage and food preservation markets. It also offers TerraMG, a mustard-derived soil biopesticide technology. In addition, the company is developing TerraSante, an organic soil amendment and biofertility technology. Further, it sells biostimulants, micronutrients, nitrogen stabilizers, and foliars. Additionally, the company offers biological and regenerative agriculture solutions to support sustainable farming. The company was formerly known as Duport Capital Ltd. and changed its name to MustGrow Biologics Corp. in March 2018. MustGrow Biologics Corp. was incorporated in 2014 and is headquartered in Saskatoon, Canada.
Financials
- Revenue (TTM)
- $9.51M
- EBITDA
- $-4.27M
- Profit Margin
- -58.53%
- ROE (TTM)
- -222.54%
- EPS (Diluted)
- -0.08
- Book Value
- 0.07
Classification
- Sector
- Materials
- Industry
- Chemicals
- Group
- Materials
Free newsletter
The Saturday TSX Wrap
The week on the TSX, in five minutes
- The biggest gainers and losers, and why they moved
- Sector and momentum moves at a glance
- The Canadian market stories you missed
Explore More
Common Questions About MGRO
Market movers
Recent TSX-V movers
Top 1-day gainers — updated from our Canadian movers feed.
Latest MGRO news
Wire stories from the last 10 days. Links open the original publisher.
- MustGrow Appoints Kevin Helash as Chief Executive Officer
Yahoo Finance · 9d ago